Clinical Impact of Breast Cancer Stem Cells in Metastatic Breast Cancer Patients
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical Impact of Breast Cancer Stem Cells in Metastatic Breast Cancer Patients
Authors
Keywords
-
Journal
Journal of Oncology
Volume 2020, Issue -, Pages 1-8
Publisher
Hindawi Limited
Online
2020-06-28
DOI
10.1155/2020/2561726
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target
- (2015) Yongmin Yan et al. Stem Cells Translational Medicine
- Reversing paclitaxel resistance in ovarian cancer cells via inhibition of the ABCB1 expressing side population
- (2014) Rachel Eyre et al. TUMOR BIOLOGY
- CD44+/CD24− ovarian cancer cells demonstrate cancer stem cell properties and correlate to survival
- (2012) Erhong Meng et al. CLINICAL & EXPERIMENTAL METASTASIS
- Breast cancer stem cells
- (2012) Marco A. Velasco-Velázquez et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- A CD44−/CD24+ phenotype is a poor prognostic marker in early invasive breast cancer
- (2011) Mohamed A. H. Ahmed et al. BREAST CANCER RESEARCH AND TREATMENT
- An increase in cancer stem cell population after primary systemic therapy is a poor prognostic factor in breast cancer
- (2011) H E Lee et al. BRITISH JOURNAL OF CANCER
- Examining the role of cyclin D1 in breast cancer
- (2011) Marco A Velasco-Velázquez et al. Future Oncology
- CD44+/CD24−/low cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome
- (2011) Michael O. Idowu et al. HUMAN PATHOLOGY
- Cells of origin in cancer
- (2011) Jane E. Visvader NATURE
- Prognostic significance of CD24 and claudin-7 immunoexpression in ductal invasive breast cancer
- (2011) M. Brentani ONCOLOGY REPORTS
- Downregulation of CD44 reduces doxorubicin resistance of CD44+CD24- breast cancer cells
- (2011) Pham Van Phuc et al. OncoTargets and Therapy
- Different prognostic significance of CD24 and CD44 expression in breast cancer according to hormone receptor status
- (2010) Hee Jeong Kim et al. BREAST
- Heterogeneity for Stem Cell-Related Markers According to Tumor Subtype and Histologic Stage in Breast Cancer
- (2010) S. Y. Park et al. CLINICAL CANCER RESEARCH
- Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse models
- (2010) H. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mullerian inhibiting substance preferentially inhibits stem/progenitors in human ovarian cancer cell lines compared with chemotherapeutics
- (2010) X. Wei et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Permanently Blocked Stem Cells Derived From Breast Cancer Cell Lines
- (2010) Gangadharan B. Sajithlal et al. STEM CELLS
- Expression of aldehyde dehydrogenase 1 (ALDH1) is associated with basal-like markers and features of aggressive tumours in African breast cancer
- (2009) H Nalwoga et al. BRITISH JOURNAL OF CANCER
- Immunoselection of Breast and Ovarian Cancer Cells with Trastuzumab and Natural Killer Cells: Selective Escape of CD44high/CD24low/HER2low Breast Cancer Stem Cells
- (2009) F. Reim et al. CANCER RESEARCH
- Stem cell marker aldehyde dehydrogenase 1-positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression
- (2009) Koji Morimoto et al. CANCER SCIENCE
- Association of Breast Cancer Stem Cells Identified by Aldehyde Dehydrogenase 1 Expression with Resistance to Sequential Paclitaxel and Epirubicin-Based Chemotherapy for Breast Cancers
- (2009) T. Tanei et al. CLINICAL CANCER RESEARCH
- Aldehyde Dehydrogenase 1-Positive Cancer Stem Cells Mediate Metastasis and Poor Clinical Outcome in Inflammatory Breast Cancer
- (2009) E. Charafe-Jauffret et al. CLINICAL CANCER RESEARCH
- Beyond Trastuzumab: Overcoming Resistance to Targeted HER-2 Therapy in Breast Cancer
- (2009) Philippe Bedard et al. CURRENT CANCER DRUG TARGETS
- Reduction of CD44+/CD24− breast cancer cells by conventional cytotoxic chemotherapy
- (2009) Sebastian Aulmann et al. HUMAN PATHOLOGY
- The clinicopathologic and prognostic significance of CD44+/CD24−/low and CD44−/CD24+ tumor cells in invasive breast carcinomas
- (2008) Eleni Mylona et al. HUMAN PATHOLOGY
- Implications of the Cancer Stem-Cell Hypothesis for Breast Cancer Prevention and Therapy
- (2008) Madhuri Kakarala et al. JOURNAL OF CLINICAL ONCOLOGY
- Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy
- (2008) X. Li et al. JNCI-Journal of the National Cancer Institute
- Commentary: The Year in Basic Science: Update of Estrogen Plus Progestin Therapy for Menopausal Hormone Replacement Implicating Stem Cells in the Increased Breast Cancer Risk
- (2008) Kathryn B. Horwitz MOLECULAR ENDOCRINOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now